Literature DB >> 3690111

Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies.

A S Hale1, A W Procter, P K Bridges.   

Abstract

Seven patients suffering from severe endogenous depression who had proven resistant to lengthy trials of treatment with tricyclic and other antidepressants are described. Their successful treatment with a combination of clomipramine, L-tryptophan and lithium is discussed in the context of other strategies for the treatment of resistant depression.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3690111     DOI： 10.1192/bjp.151.2.213

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  5 in total

1.  Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.

Authors:  R D Levitan; J H Shen; R Jindal; H S Driver; S H Kennedy; C M Shapiro
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

2.  Depression resistant to tricyclic antidepressants.

Authors:  P J Cowen
Journal:  BMJ       Date:  1988-08-13

3.  Lithium increases 5-HT-mediated prolactin release.

Authors:  S L McCance; P R Cohen; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 4.  Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.

Authors:  K L Dechant; S P Clissold
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

Review 5.  Use of tryptophan in combination with other antidepressant treatments: a review.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1991-12       Impact factor: 6.186
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.